D89.44 Billable / specific Hereditary alpha tryptasemia

ICD-10-CM D89.44 identifies “Hereditary alpha tryptasemia” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Code-level instructions

Use additional code3
  • code, if applicable, for:
  • allergy status, other than to drugs and biological substances (Z91.0-)
  • personal history of anaphylaxis (Z87.892)

Inherited instructions

Chapters 3 · Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)

Excludes 29
  • autoimmune disease (systemic) NOS (M35.9)
  • certain conditions originating in the perinatal period (P00-P96)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • human immunodeficiency virus [HIV] disease (B20)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

D80-D89 · Certain disorders involving the immune mechanism (D80-D89)

Includes3
  • defects in the complement system
  • immunodeficiency disorders, except human immunodeficiency virus [HIV] disease
  • sarcoidosis
Excludes 12
  • autoimmune disease (systemic) NOS (M35.9)
  • functional disorders of polymorphonuclear neutrophils (D71-)
Excludes 21

human immunodeficiency virus [HIV] disease (B20)

D89 · Other disorders involving the immune mechanism, not elsewhere classified

Excludes 12
  • hyperglobulinemia NOS (R77.1)
  • monoclonal gammopathy (of undetermined significance) (D47.2)
Excludes 21

transplant failure and rejection (T86.-)

D89.4 · Mast cell activation syndrome and related disorders

Excludes 111
  • aggressive systemic mastocytosis (C96.21)
  • congenital cutaneous mastocytosis (Q82.2)
  • (non-congenital) cutaneous mastocytosis (D47.01)
  • (indolent) systemic mastocytosis (D47.02)
  • malignant mast cell neoplasm (C96.2-)
  • malignant mastocytoma (C96.29)
  • mast cell leukemia (C94.3-)
  • mast cell sarcoma (C96.22)
  • mastocytoma NOS (D47.09)
  • other mast cell neoplasms of uncertain behavior (D47.09)
  • systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
Official index references

Official index references (3)

Hereditary alpha tryptasemia(syndrome) (1)
Syndrome (1)
Tryptasemia, hereditary alpha (1)

Official conversion history

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Release dates 2021-10-01

Previous assignment: D89.49

History

Code history

Latest recorded change · FY2027

ChangedUnchanged
FY2027Selected edition

Effective from

  • Inherited rules changed

Hereditary alpha tryptasemia

Billable diagnosis code

CDC/NCHS · FY2027

All editions (11)

All editionsEffective fromCode history
FY20222021-10-01Added
FY2022 · 04-012022-04-01No tabular change
FY20232022-10-01No tabular change
FY2023 · 04-012023-04-01No tabular change
FY20242023-10-01No tabular change
FY2024 · 04-012024-04-01No tabular change
FY20252024-10-01No tabular change
FY2025 · 04-012025-04-01No tabular change
FY20262025-10-01Inherited rules changed
FY2026 · April2026-04-01No tabular change
FY20272026-10-01Inherited rules changed

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.